What's Happening?
The Centers for Disease Control and Prevention (CDC) has conducted a public health impact evaluation of its CDC-Funded Vector-Borne Disease Centers of Excellence Program, covering the period from 2017
to 2022. This evaluation, detailed in an early release article in the Emerging Infectious Diseases journal, assesses the effectiveness and reach of these programs across the United States. The program aims to combat diseases transmitted by vectors such as mosquitoes and ticks, which pose significant public health challenges. The evaluation provides insights into the strategies employed by these centers and their contributions to disease surveillance, prevention, and control efforts. The findings are crucial for understanding the ongoing fight against vector-borne illnesses and for guiding future public health initiatives in this area. The article, authored by Jeremy P. Ledermann, Lars Eisen, and Jeff N. Borchert, is part of a supplement issue scheduled for December 2026.
Why It's Important?
This evaluation is important because vector-borne diseases, such as West Nile virus, Lyme disease, and Zika, continue to be a significant public health concern in the U.S., with their prevalence and geographic spread often influenced by environmental factors. The CDC's program aims to mitigate these threats through coordinated research, surveillance, and public health interventions. Understanding the impact of these Centers of Excellence helps policymakers and public health officials allocate resources effectively and refine strategies to protect communities. The findings can highlight successful approaches that can be replicated nationwide and identify areas where improvements are needed. This assessment also informs the public about the efforts being made to control these diseases, which can have severe health consequences and place a substantial burden on healthcare systems.
What's Next?
The findings from this evaluation will likely inform future funding decisions and strategic planning for vector-borne disease control programs within the CDC and other public health organizations. Recommendations derived from the evaluation could lead to adjustments in program priorities, resource allocation, and the implementation of new or modified intervention strategies. Public health agencies at state and local levels may use these insights to enhance their own vector control efforts. Further research may also be spurred by the evaluation's conclusions, focusing on areas identified as needing more attention or innovative solutions. The full release of the article in December 2026 will provide a comprehensive overview for public health professionals and researchers.
Beyond the Headlines
The ongoing evaluation of vector-borne disease programs underscores the dynamic nature of public health challenges, particularly those influenced by environmental changes. As climate patterns shift, the geographic range and incidence of vector-borne diseases are expected to evolve, making continuous monitoring and adaptive strategies essential. This evaluation reflects a broader commitment to evidence-based public health practice, where programs are regularly assessed for their effectiveness and efficiency. The collaboration between various public health entities, as facilitated by these Centers of Excellence, is critical for a unified and robust response to emerging and re-emerging infectious diseases. The long-term implications involve not only disease control but also the development of resilient public health infrastructures capable of responding to future biological threats.








